COVID-19 will become endemic by 2024 globally: Pharmaceutical firm Pfizer

Pharmaceutical firm Pfizer on Friday said that COVID-19 will transition to an endemic state around the globe by 2024. Pfizer's Chief Scientific Officer Mikael Dolsten also announced plans to develop a three-dose vaccine regimen for children aged 2 to 16. Dolsten said that results of three doses among people older than 16 showed that approach offered greater protection.